| 2025 | 2024 | 2023 | 2022 | 2021 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 1,8 M € | -20.4% | 2,2 M € | -4.0% | 2,3 M € | +13.8% | 2,0 M € | -0.0% | 2,0 M € | +7.7% | 1,9 M € | +2.1% | 1,9 M € | -12.8% | 2,1 M € | +4.6% | 2,0 M € | +3.9% | 2,0 M € | +10.2% | 1,8 M € | +3.1% | 1,7 M € | +1.9% | 1,7 M € | -1.2% | 1,7 M € | +4.6% | 1,6 M € | +11.9% | 1,5 M € | +2.6% | 1,4 M € | +15.0% | 1,2 M € | |
| EBITDA | -419,0 k € | -230.2% | 321,9 k € | +22.1% | 263,6 k € | +107.0% | 127,3 k € | -60.8% | 324,4 k € | -41.4% | 553,7 k € | +36.4% | 406,1 k € | -51.4% | 836,0 k € | +26.9% | 658,6 k € | +30.5% | 504,6 k € | +9.6% | 460,5 k € | +10.5% | 416,5 k € | -4.0% | 433,8 k € | -11.4% | 489,7 k € | -5.5% | 517,9 k € | +37.5% | 376,6 k € | +16.5% | 323,2 k € | +19.5% | 270,4 k € | |
| Operating profit | -628,0 k € | -648.7% | 114,4 k € | +58.7% | 72,1 k € | +3352.8% | 2,1 k € | -99.0% | 210,7 k € | -35.2% | 325,3 k € | +99.7% | 162,9 k € | -69.8% | 540,2 k € | +33.0% | 406,1 k € | +64.9% | 246,3 k € | -6.2% | 262,6 k € | +22.5% | 214,4 k € | -3.3% | 221,6 k € | -9.0% | 243,6 k € | -8.0% | 264,8 k € | +38.8% | 190,8 k € | +42.3% | 134,1 k € | -27.4% | 184,7 k € | |
| Profit/loss | -677,7 k € | -2592.1% | 27,2 k € | -32.7% | 40,4 k € | +428.6% | -12,3 k € | -108.3% | 147,5 k € | -31.9% | 216,5 k € | +131.7% | 93,5 k € | -73.3% | 350,6 k € | +37.6% | 254,8 k € | +69.7% | 150,1 k € | -4.5% | 157,2 k € | +19.6% | 131,4 k € | -12.8% | 150,7 k € | -5.6% | 159,5 k € | -3.4% | 165,1 k € | +40.5% | 117,5 k € | +30.3% | 90,2 k € | -30.9% | 130,5 k € | |
| Equity | 692,8 k € | -49.4% | 1,4 M € | +2.0% | 1,3 M € | +3.1% | 1,3 M € | -0.9% | 1,3 M € | +24.9% | 1,1 M € | -34.4% | 1,6 M € | +6.2% | 1,5 M € | +30.2% | 1,2 M € | +27.4% | 910,5 k € | +18.2% | 770,4 k € | +25.6% | 613,2 k € | -21.6% | 781,8 k € | -22.3% | 1,0 M € | +18.8% | 846,6 k € | +24.2% | 681,5 k € | +20.8% | 563,9 k € | +19.0% | 473,7 k € | |
| Total assets | 3,6 M € | -12.1% | 4,1 M € | +5.6% | 3,9 M € | +27.2% | 3,1 M € | +17.7% | 2,6 M € | +17.3% | 2,2 M € | -22.7% | 2,9 M € | +2.9% | 2,8 M € | +8.1% | 2,6 M € | +17.3% | 2,2 M € | +10.5% | 2,0 M € | +1.5% | 2,0 M € | -11.5% | 2,2 M € | +5.6% | 2,1 M € | +14.1% | 1,8 M € | +21.8% | 1,5 M € | -1.3% | 1,5 M € | +9.9% | 1,4 M € | |
| Cash | 195,3 k € | -41.7% | 335,2 k € | +12.7% | 297,5 k € | +83.4% | 162,2 k € | -81.5% | 878,8 k € | +368.8% | 187,4 k € | +21.6% | 154,2 k € | -46.1% | 285,8 k € | +91.8% | 149,0 k € | +49.0% | 100,0 k € | +6.2% | 94,2 k € | -26.7% | 128,4 k € | +108.8% | 61,5 k € | -92.5% | 817,9 k € | +17.6% | 695,6 k € | +815.9% | 75,9 k € | -50.0% | 151,8 k € | -71.6% | 535,3 k € | |
| Debts | 2,9 M € | +6.6% | 2,8 M € | +7.5% | 2,6 M € | +45.0% | 1,8 M € | +39.7% | 1,3 M € | +10.8% | 1,1 M € | +12.2% | 1,0 M € | -2.9% | 1,0 M € | -6.7% | 1,1 M € | +8.4% | 1,0 M € | -8.0% | 1,1 M € | -11.7% | 1,3 M € | -0.7% | 1,3 M € | +36.7% | 938,3 k € | +10.6% | 848,3 k € | +8.3% | 783,4 k € | -13.5% | 905,2 k € | +1.6% | 890,9 k € | |
| Staff | 40,1 | 38,3 | 41,1 | 39,2 | 39,9 | 39,9 | 40,2 | 38,6 | 37,3 | 35,7 | 38,7 | 37 | 37,6 | 36,7 | 34,6 | 34,2 | 35,3 | 35,7 | ||||||||||||||||||
Public limited company · Deinze · incorporated on 01/01/1968 · 40,1 ETP
Public limited company loss-making in the latest fiscal year. Cash position declining (-41.7%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Laboratoria Bota is a Public limited company incorporated in 1968. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Deinze. It employs on average 40,1 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette